IMRX - Immuneering Corp - Ordinary Shares Class A
IEX Last Trade
1.11
-0.050 -4.505%
Share volume: 264,507
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.16
-0.05
-4.31%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-10 | 2022-08-10 | 2022-11-10 | 2023-03-06 | 2023-05-04 | 2023-08-03 | 2023-11-09 | |
| Total revenue | 183.698 K | 94.419 K | 38.380 K | 455.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 90.846 K | 47.933 K | 19.343 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 92.852 K | 46.486 K | 19.037 K | 455.000 | 0.000 | 0.000 | 0.000 | |
| -49.94% | -59.05% | -97.61% | -100.00% | nan% | nan% | |||
| Operating expenses | 13.010 M | 11.685 M | 13.200 M | 13.978 M | 14.672 M | 13.498 M | 13.919 M | |
| Selling general and admin | 3.952 M | 3.704 M | 3.836 M | 4.114 M | 4.461 M | 4.045 M | 3.869 M | |
| Research and development | 9.059 M | 7.981 M | 9.364 M | 9.864 M | 10.211 M | 9.453 M | 10.050 M | |
| Total expenses | 13.109 M | 11.740 M | 13.227 M | 13.985 M | 14.680 M | 13.505 M | 13.926 M | |
| -10.44% | 12.66% | 5.74% | 4.96% | -8.00% | 3.12% | |||
| Operating income | -12.926 M | -11.646 M | -13.188 M | -13.985 M | -14.680 M | -13.505 M | -13.926 M | |
| Ebit | -12.926 M | -11.646 M | -13.188 M | -13.985 M | -14.680 M | -13.505 M | -13.926 M | |
| Pretax income | -12.896 M | -11.527 M | -12.844 M | -13.246 M | -13.604 M | -12.189 M | -12.595 M | |
| -10.62% | 11.43% | 3.12% | 2.71% | -10.40% | 3.33% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -12.896 M | -11.527 M | -12.844 M | -13.246 M | -13.604 M | -12.189 M | -12.595 M | |
| 10.62% | -11.43% | -3.12% | -2.71% | 10.40% | -3.33% | |||
| Net income | -12.896 M | -11.527 M | -12.844 M | -13.246 M | -13.604 M | -12.189 M | -12.595 M | |
| 10.62% | -11.43% | -3.12% | -2.71% | 10.40% | -3.33% |